Jonathan Yong
Stock Analyst at UBS
(2.63)
# 2,052
Out of 5,131 analysts
95
Total ratings
61.11%
Success rate
11.45%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $17.73 | -4.12% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $4.00 | +25.00% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.60 | +15.38% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $9.97 | +20.36% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.80 | +185.71% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $8.24 | +215.53% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $31.69 | -55.82% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $77.64 | +23.65% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $15.22 | +110.25% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $15.31 | +585.83% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $102.93 | -22.28% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $251.81 | -8.26% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.46 | +261.93% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $201.11 | -50.28% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $816.06 | -44.86% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.55 | +370.59% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $5.17 | +1,253.97% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $19.31 | -11.96% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $181.50 | +92.84% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $13.53 | +602.14% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $2.38 | +257.14% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.03 | +78.03% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.32 | +156.02% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $80.81 | +5.19% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $174.44 | -16.30% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $46.61 | +127.42% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $207.03 | -24.17% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $278.95 | +31.92% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $276.85 | +129.37% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $80.30 | +45.70% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $22.34 | +34.29% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $472.07 | -36.87% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $201.20 | -52.78% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $343.98 | +43.90% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $17.73
Upside: -4.12%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.00
Upside: +25.00%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.60
Upside: +15.38%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $9.97
Upside: +20.36%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.80
Upside: +185.71%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $8.24
Upside: +215.53%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $31.69
Upside: -55.82%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $77.64
Upside: +23.65%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.22
Upside: +110.25%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $15.31
Upside: +585.83%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $102.93
Upside: -22.28%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $251.81
Upside: -8.26%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.46
Upside: +261.93%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $201.11
Upside: -50.28%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $816.06
Upside: -44.86%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.55
Upside: +370.59%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $5.17
Upside: +1,253.97%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $19.31
Upside: -11.96%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $181.50
Upside: +92.84%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $13.53
Upside: +602.14%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $2.38
Upside: +257.14%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.03
Upside: +78.03%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.32
Upside: +156.02%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $80.81
Upside: +5.19%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $174.44
Upside: -16.30%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $46.61
Upside: +127.42%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $207.03
Upside: -24.17%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $278.95
Upside: +31.92%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $276.85
Upside: +129.37%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $80.30
Upside: +45.70%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $22.34
Upside: +34.29%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $472.07
Upside: -36.87%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $201.20
Upside: -52.78%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $343.98
Upside: +43.90%